Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes
Journal
Oncotarget
Journal Volume
8
Journal Issue
32
Pages
53028
Date Issued
2017-08-08
Author(s)
Abstract
Dipeptidyl peptidase 4 inhibitor (DPP4i) use potentially slows the progression of diabetic kidney disease, but its effects on the risk of acute kidney injury (AKI) are unclear. We aimed to assess the association between DPP4i use and incident AKI episodes from a nationally representative cohort in Taiwan.
Subjects
acute kidney injury; chronic kidney disease; diabetes mellitus; dialysis-requiring acute kidney injury; dipeptidyl peptidase 4 inhibitor
SDGs
Publisher
IMPACT JOURNALS LLC
Type
journal article